AI English summary of an SEC filing — figures as filed

The company said its revenue for Q3 2024 was $2.04 billion, up 17% from $1.74 billion in Q3 2023, and that worldwide da Vinci procedures grew about 18%.

8-KResults of Operations and Financial ConditionFiled Oct 17, 2024Period of report Oct 17, 2024Summary published (UTC) Oct 20, 2026

Key points

AI summary

The company said its revenue for Q3 2024 was $2.04 billion, up 17% from $1.74 billion in Q3 2023, and that worldwide da Vinci procedures grew about 18%.
The company said it placed 379 da Vinci surgical systems in Q3 2024 (312 in Q3 2023), of which 110 were da Vinci 5. It said its installed base was 9,539 systems as of September 30, 2024, up 15% from 8,285 at the end of Q3 2023.
The company said its cash, cash equivalents, and investments totaled $8.31 billion as of the end of Q3 2024, an increase of $628 million during the quarter. It attributed the increase mainly to cash generated from operations, partially offset by capital expenditures.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call. Some paragraphs were omitted because their support in the source could not be confirmed.

Q3 2024 Revenue $2.04 billion

The company said its revenue for Q3 2024 was $2.04 billion, up 17% from $1.74 billion in Q3 2023, and that worldwide da Vinci procedures grew about 18%.

Source · Based on the filing body and exhibits

da Vinci 379 Systems Placed, da Vinci 5 110 Systems

The company said it placed 379 da Vinci surgical systems in Q3 2024 (312 in Q3 2023), of which 110 were da Vinci 5. It said its installed base was 9,539 systems as of September 30, 2024, up 15% from 8,285 at the end of Q3 2023.

Source · Based on the filing body and exhibits

Cash and Other $8.31 billion, Up $628 million During Quarter

The company said its cash, cash equivalents, and investments totaled $8.31 billion as of the end of Q3 2024, an increase of $628 million during the quarter. It attributed the increase mainly to cash generated from operations, partially offset by capital expenditures.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.